BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 319 filers reported holding BIONTECH SE in Q4 2022. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,993,731 | +148.5% | 73,580 | +146.8% | 0.03% | +170.0% |
| Q2 2023 | $3,217,393 | -11.1% | 29,810 | +2.6% | 0.01% | -23.1% |
| Q1 2023 | $3,621,001 | -51.4% | 29,068 | -41.4% | 0.01% | -23.5% |
| Q4 2022 | $7,453,165 | +10.5% | 49,615 | -0.7% | 0.02% | +30.8% |
| Q3 2022 | $6,742,000 | -52.8% | 49,986 | -47.8% | 0.01% | -40.9% |
| Q2 2022 | $14,280,000 | -59.6% | 95,775 | -53.7% | 0.02% | -37.1% |
| Q1 2022 | $35,309,000 | -7.2% | 207,018 | +40.2% | 0.04% | +12.9% |
| Q4 2021 | $38,060,000 | +48.9% | 147,634 | +57.7% | 0.03% | +10.7% |
| Q3 2021 | $25,563,000 | +75.7% | 93,642 | +44.1% | 0.03% | +55.6% |
| Q2 2021 | $14,550,000 | +92.2% | 64,991 | -6.3% | 0.02% | +63.6% |
| Q1 2021 | $7,571,000 | +432.0% | 69,335 | +297.1% | 0.01% | +450.0% |
| Q4 2020 | $1,423,000 | +318.5% | 17,461 | +255.5% | 0.00% | +100.0% |
| Q3 2020 | $340,000 | -41.7% | 4,912 | -43.8% | 0.00% | -66.7% |
| Q2 2020 | $583,000 | – | 8,737 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |